A novel TaqMAMA assay for allelic discrimination of immunoproteasome subunit PSMB8 in pediatric patients

Minerva Pediatr (Torino). 2022 Jun;74(3):301-307. doi: 10.23736/S2724-5276.16.04675-2. Epub 2016 Dec 22.

Abstract

Background: A more recent improvement in MAMA was made when the allele selectivity of MAMA primers was combined with the 5' fluorogenic exonuclease (TaqMan) assay. This strategy referred to as TaqMAMA.

Methods: A SNP rs9357155 at the PSMB8 locus (GenBank access number NM_148919.3.) on chromosome 6 showing a C/T transition in position 32842071, has been chosen as model in this study.

Results: Tested assays have provided to be linear over two log10 of magnitude and have efficiencies close to the average of 80.3%. Average interference limit values of TaqMAMA have been considered around the 0.6%. Coefficient of variation (CV) for PSMB8c and t were approximatively 1%.

Conclusions: Prevalidation procedure described in this paper can be applied, not only to the allele quantification, but also to many other real time PCR applications.

MeSH terms

  • Alleles*
  • Child
  • DNA Primers / genetics
  • Humans
  • Polymorphism, Single Nucleotide
  • Proteasome Endopeptidase Complex* / genetics
  • Real-Time Polymerase Chain Reaction / methods

Substances

  • DNA Primers
  • LMP7 protein
  • Proteasome Endopeptidase Complex